novo nordisk
Denmark's Novo Nordisk faces diminished profits and price-fixing lawsuit in US
Denmark's Novo Nordisk, the world's top insulin maker, said on Thursday its 2016 net profit was below forecasts due to falling product prices in the US, a huge market for the company.